Target- |
MechanismPhotosensitizers |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CA |
First Approval Date01 Jan 1993 |
Establishment of a Registry for Patients Treated With Photodynamic Therapy (PDT)
This is a non-intervention patient registry to gather data on the use of photodynamic therapy under real-life conditions. It will involve up to 20 sites in USA.
Multi-Center, Randomized Trial of Photodynamic Therapy Versus Argon Plasma Coagulation for Lung Cancer With Endobronchial Obstruction
The purpose of the study is to assess the efficacy of photodynamic therapy (PDT) in relieving airway obstruction in subjects with lung cancer compared to treatment with argon plasma coagulation (APC).
A Multicenter, Prospective, Open-label, Non-randomized Single-arm Clinical Study of the Safety and Tissue Response to Photodynamic Therapy Using Porfimer Sodium for Injection as Treatment for Solid Lung Tumor Prior to Surgical Resection
This research study is being conducted to assess the safety of PDT in subjects with peripherally located malignant tumors in lung parenchyma prior to surgical resection. It will involve up to 10 sites in USA. Participation will last 4 months.
100 Clinical Results associated with Concordia Laboratories, Inc.
0 Patents (Medical) associated with Concordia Laboratories, Inc.
100 Deals associated with Concordia Laboratories, Inc.
100 Translational Medicine associated with Concordia Laboratories, Inc.